Physician profile
Alan Cohen
NPI 1598836280
$694.46
in general payments reported to CMS, 2019-2025
13 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.49 · 2021: $141 · 2022: $244 · 2023: $132 · 2024: $45.59 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.16 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $230.92 | 2021-2023 | Dupixent |
| Incyte Corporation | $119.86 | 2022-2025 | Opzelura |
| Abbvie INC. | $77.92 | 2022-2025 | |
| Lilly USA, LLC | $51.19 | 2020-2023 | Taltz, Olumiant |
| Genzyme Corporation | $47.85 | 2021-2025 | |
| Dermavant Sciences, INC. | $46.18 | 2023 | Vtama |
| Amgen INC. | $35.21 | 2024-2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $16.05 | 2023 | Sotyktu |
| Janssen Biotech, INC. | $15.29 | 2021 | |
| Pfizer INC. | $14.63 | 2023 | |
| Arcutis Biotherapeutics, INC. | $14.51 | 2024 | Zoryve |
| Sun Pharmaceutical Industries INC. | $13.55 | 2020 | |
| Genentech USA, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.